Adrian Urgent Care Pllc - Medicare Primary Care in Adrian, MI

Adrian Urgent Care Pllc is a medicare enrolled primary clinic (Family Medicine) in Adrian, Michigan. The current practice location for Adrian Urgent Care Pllc is 715 N Main St, Adrian, Michigan. For appointments, you can reach them via phone at (248) 957-7999. The mailing address for Adrian Urgent Care Pllc is 2692 Solutions Center Dr, Chicago, Illinois and phone number is (248) 957-7999.

Adrian Urgent Care Pllc is licensed to practice in Michigan (license number 4301063833). The clinic also participates in the medicare program and its NPI number is 1003204769. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (248) 957-7999.

Contact Information

Adrian Urgent Care Pllc
715 N Main St
Adrian
MI 49221-2151
(248) 957-7999
(248) 957-7997

Primary Care Clinic Profile

Full NameAdrian Urgent Care Pllc
SpecialityFamily Medicine
Location715 N Main St, Adrian, Michigan
Authorized Official Name and PositionFarah Iftikhar (PRESIDENT)
Authorized Official Contact2489577999
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Adrian Urgent Care Pllc
2692 Solutions Center Dr
Chicago
IL 60677-0001

Ph: (248) 957-7999
Adrian Urgent Care Pllc
715 N Main St
Adrian
MI 49221-2151

Ph: (248) 957-7999

NPI Details:

NPI Number1003204769
Provider Enumeration Date01/05/2015
Last Update Date10/17/2023

Medicare PECOS Information:

Medicare PECOS PAC ID5193045425
Medicare Enrollment IDO20150527002240

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Adrian Urgent Care Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003204769NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 4301063833 (Michigan)Primary
207R00000XInternal Medicine 4301063833 (Michigan)Secondary
261QU0200XClinic/center - Urgent Care (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Adrian Urgent Care Pllc acts as a billing entity for following providers:
Provider NameFarah Iftikhar
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1376542035
PECOS PAC ID: 1052396561
Enrollment ID: I20040623000290

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameLaurie A Barkway
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1003870031
PECOS PAC ID: 9133195506
Enrollment ID: I20040907001289

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NamePadmaja R Mouli
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1821102633
PECOS PAC ID: 3971555855
Enrollment ID: I20050221000008

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameAli M Khan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1306890405
PECOS PAC ID: 0244325512
Enrollment ID: I20071002000039

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameChong U Yi
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1366641573
PECOS PAC ID: 0244328169
Enrollment ID: I20071109000620

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameLeonor M Franklin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366753949
PECOS PAC ID: 2062607526
Enrollment ID: I20101109001528

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameArshia Akram
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982894317
PECOS PAC ID: 8729225883
Enrollment ID: I20130508000410

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameVijay Singh Saini
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1043544810
PECOS PAC ID: 2466693494
Enrollment ID: I20130802000123

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameCalder B Conner
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1770537433
PECOS PAC ID: 1052327095
Enrollment ID: I20130824000236

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameAngelena M Valdez
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871032151
PECOS PAC ID: 4183952708
Enrollment ID: I20190821000554

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

Provider NameLori Jacobs
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154890085
PECOS PAC ID: 5092115022
Enrollment ID: I20210614002005

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more Medical News

› Verified 4 days ago

News Archive

Increasing numbers of blood collection centers in parts of China contributing to spread of HIV

The increasing number of blood-collection centers in parts of China is posing a threat to vulnerable populations and placing them at an increased risk of HIV transmission, some Chinese HIV/AIDS advocates have said recently, the Boston Globe reports.

New investigational therapy for the treatment of bladder cancer

A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer.

Quad partners with University of Massachusetts to evaluate performance of novel cell separation solution

The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

Malaria parasites' decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

Read more News

› Verified 4 days ago


Family Medicine in Adrian, MI

Hospitalist Medicine Physicians Of Michigan, Pllc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 818 Riverside Ave, Adrian, MI 49221
Phone: 330-493-4443    Fax: 330-493-8677
Hospitalist Medicine Physicians Of Michigan Pllc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 818 Riverside Ave, Adrian, MI 49221
Phone: 517-265-0900    
Internal Medicine Associates Of Adrian Pc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 781 Lakeshire Trl, Adrian, MI 49221
Phone: 517-263-2187    Fax: 517-263-0024
Family Medical Center-springbrook Middle School
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 615 Springbrook Ave, Adrian, MI 49221
Phone: 734-654-2169    Fax: 734-850-0520
Heffron Clinic, P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 755 High St, Adrian, MI 49221
Phone: 517-265-2175    Fax: 517-264-5926
Family Medical Center Of Mi, Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1200 N Main St, Adrian, MI 49221
Phone: 517-263-1800    Fax: 517-263-1866

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.